Investment
Features
FeesSafety
Academy
More
Pluang+

Venture Global aims to be top U.S. LNG exporter by 2027, raising 2026 EBITDA guidance amid strong gas prices.

Company Fundamentals
15 Sep 2026
Seeking Alpha
View Source
Bullish
Venture Global aims to be top U.S. LNG exporter by 2027, raising 2026 EBITDA guidance amid strong gas prices.

Venture Global is on track to become the largest U.S. LNG exporter by 2027, with key projects progressing as planned. The company has raised its 2026 EBITDA guidance and is expected to increase it further, potentially reaching close to $10 billion, driven by strong gas prices. Despite possible short-term volatility, the stock is considered attractive for long-term investors. Risks include project delays, geopolitical issues like the Iran resolution, and market optimism about 2027 when EBITDA is expected to normalize to $8 billion.

Venture Global LNG is the subject of this update. For readers following energy markets, here is Pluang's snapshot as of Sep 15, 2026 17:23 WIB: Out of 30 priced US energy stocks, 21 rose and 8 fell today. Notable movers include CNQ at USD 50.73 (+0.81%), WMB at USD 72.53 (+0.81%), and VLO at USD 385.83 (+0.75%).

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App